These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 28092856)

  • 1. Separation of antibody drug conjugate species by RPLC: A generic method development approach.
    Fekete S; Molnár I; Guillarme D
    J Pharm Biomed Anal; 2017 Apr; 137():60-69. PubMed ID: 28092856
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of antibody-drug conjugates by comprehensive on-line two-dimensional hydrophobic interaction chromatography x reversed phase liquid chromatography hyphenated to high resolution mass spectrometry. I - Optimization of separation conditions.
    Sarrut M; Corgier A; Fekete S; Guillarme D; Lascoux D; Janin-Bussat MC; Beck A; Heinisch S
    J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Oct; 1032():103-111. PubMed ID: 27426266
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of antibody-drug conjugates by comprehensive on-line two-dimensional hydrophobic interaction chromatography x reversed phase liquid chromatography hyphenated to high resolution mass spectrometry. II- Identification of sub-units for the characterization of even and odd load drug species.
    Sarrut M; Fekete S; Janin-Bussat MC; Colas O; Guillarme D; Beck A; Heinisch S
    J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Oct; 1032():91-102. PubMed ID: 27426265
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimization of non-linear gradient in hydrophobic interaction chromatography for the analytical characterization of antibody-drug conjugates.
    Bobály B; Randazzo GM; Rudaz S; Guillarme D; Fekete S
    J Chromatogr A; 2017 Jan; 1481():82-91. PubMed ID: 28017562
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Practical method development for the separation of monoclonal antibodies and antibody-drug-conjugate species in hydrophobic interaction chromatography, part 1: optimization of the mobile phase.
    Rodriguez-Aller M; Guillarme D; Beck A; Fekete S
    J Pharm Biomed Anal; 2016 Jan; 118():393-403. PubMed ID: 26609679
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is hydrophobic interaction chromatography the most suitable technique to characterize site-specific antibody-drug conjugates?
    D'Atri V; Pell R; Clarke A; Guillarme D; Fekete S
    J Chromatogr A; 2019 Feb; 1586():149-153. PubMed ID: 30554777
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug-to-antibody determination for an antibody-drug-conjugate utilizing cathepsin B digestion coupled with reversed-phase high-pressure liquid chromatography analysis.
    Adamo M; Sun G; Qiu D; Valente J; Lan W; Song H; Bolgar M; Katiyar A; Krishnamurthy G
    J Chromatogr A; 2017 Jan; 1481():44-52. PubMed ID: 28017567
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug-to-antibody ratio (DAR) and drug load distribution by hydrophobic interaction chromatography and reversed phase high-performance liquid chromatography.
    Ouyang J
    Methods Mol Biol; 2013; 1045():275-83. PubMed ID: 23913154
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A rapid on-line method for mass spectrometric confirmation of a cysteine-conjugated antibody-drug-conjugate structure using multidimensional chromatography.
    Birdsall RE; Shion H; Kotch FW; Xu A; Porter TJ; Chen W
    MAbs; 2015; 7(6):1036-44. PubMed ID: 26305867
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-throughput oxidation screen of antibody-drug conjugates by analytical protein A chromatography following IdeS digest.
    Buecheler JW; Winzer M; Weber C; Gieseler H
    J Pharm Pharmacol; 2018 May; 70(5):625-635. PubMed ID: 29380379
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A size exclusion-reversed phase two dimensional-liquid chromatography methodology for stability and small molecule related species in antibody drug conjugates.
    Li Y; Gu C; Gruenhagen J; Zhang K; Yehl P; Chetwyn NP; Medley CD
    J Chromatogr A; 2015 May; 1393():81-8. PubMed ID: 25818558
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Streamlined Characterization of an Antibody-Drug Conjugate by Two-Dimensional and Four-Dimensional Liquid Chromatography/Mass Spectrometry.
    Goyon A; Kim M; Dai L; Cornell C; Jacobson F; Guillarme D; Stella C
    Anal Chem; 2019 Dec; 91(23):14896-14903. PubMed ID: 31621311
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of recombinant monoclonal antibodies in hydrophilic interaction chromatography: A generic method development approach.
    Bobály B; D'Atri V; Beck A; Guillarme D; Fekete S
    J Pharm Biomed Anal; 2017 Oct; 145():24-32. PubMed ID: 28646659
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of organic modifier and temperature on protein denaturation in hydrophobic interaction chromatography.
    Bobaly B; Beck A; Veuthey JL; Guillarme D; Fekete S
    J Pharm Biomed Anal; 2016 Nov; 131():124-132. PubMed ID: 27589029
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Qualitative analysis of antibody-drug conjugates (ADCs): an experimental comparison of analytical techniques of cysteine-linked ADCs.
    Källsten M; Hartmann R; Artemenko K; Lind SB; Lehmann F; Bergquist J
    Analyst; 2018 Nov; 143(22):5487-5496. PubMed ID: 30289422
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The Characterization of Drug-to-Antibody Ratio and Isoforms of ADCs Using LC and MS Technologies].
    Iizuka R; Kotch F; Xu A; Porter T; Shion H; Birdsall R; Chen W
    Yakugaku Zasshi; 2017; 137(5):525-528. PubMed ID: 28458283
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Innovative native MS methodologies for antibody drug conjugate characterization: High resolution native MS and IM-MS for average DAR and DAR distribution assessment.
    Debaene F; Boeuf A; Wagner-Rousset E; Colas O; Ayoub D; Corvaïa N; Van Dorsselaer A; Beck A; Cianférani S
    Anal Chem; 2014 Nov; 86(21):10674-83. PubMed ID: 25270580
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Middle-Down Multi-Attribute Analysis of Antibody-Drug Conjugates with Electron Transfer Dissociation.
    Chen B; Lin Z; Zhu Y; Jin Y; Larson E; Xu Q; Fu C; Zhang Z; Zhang Q; Pritts WA; Ge Y
    Anal Chem; 2019 Sep; 91(18):11661-11669. PubMed ID: 31442030
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of an antibody-drug conjugate by hydrophilic interaction chromatography coupled to mass spectrometry.
    D'Atri V; Fekete S; Stoll D; Lauber M; Beck A; Guillarme D
    J Chromatogr B Analyt Technol Biomed Life Sci; 2018 Mar; 1080():37-41. PubMed ID: 29477065
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A sensitive multidimensional method for the detection, characterization, and quantification of trace free drug species in antibody-drug conjugate samples using mass spectral detection.
    Birdsall RE; McCarthy SM; Janin-Bussat MC; Perez M; Haeuw JF; Chen W; Beck A
    MAbs; 2016; 8(2):306-17. PubMed ID: 26651262
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.